16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Menu
Ligand Predictions Analysis
Results Home Table Browser
Target: 
Text
Models / Ligands Ligand scores
    #     Model     Group
    Name		      Target Ligand     LDDT_pli     RMSD     LDDT_lp     BB_RMSD
1. L3032LG408_2 SNU-CHEM-lig ligand_L0R_B_1.mol 0.902 0.531 0.922 0.354
2. L3032LG494_2 ClusPro ligand_L0R_B_1.mol 0.899 0.511 0.930 0.253
3. L3032LG274_2 kozakovvajda ligand_L0R_B_1.mol 0.899 0.511 0.930 0.253
4. L3032LG262_5 CoDock ligand_L0R_B_1.mol 0.898 0.531 0.916 0.336
5. L3032LG262_1 CoDock ligand_L0R_B_1.mol 0.898 0.531 0.916 0.336
6. L3032LG408_3 SNU-CHEM-lig ligand_L0R_B_1.mol 0.873 0.816 0.917 0.293
7. L3032LG274_1 kozakovvajda ligand_L0R_B_1.mol 0.873 0.808 0.925 0.253
8. L3032LG494_1 ClusPro ligand_L0R_B_1.mol 0.873 0.808 0.925 0.253
9. L3032LG274_5 kozakovvajda ligand_L0R_B_1.mol 0.865 0.862 0.930 0.253
10. L3032LG494_5 ClusPro ligand_L0R_B_1.mol 0.865 0.862 0.930 0.253
11. L3032LG494_4 ClusPro ligand_L0R_B_1.mol 0.861 0.801 0.926 0.253
12. L3032LG274_4 kozakovvajda ligand_L0R_B_1.mol 0.861 0.801 0.926 0.253
13. L3032LG204_2 Zou ligand_L0R_B_1.mol 0.857 0.765 0.890 0.394
14. L3032LG420_1 Zou_aff2 ligand_L0R_B_1.mol 0.857 0.765 0.890 0.394
15. L3032LG274_3 kozakovvajda ligand_L0R_B_1.mol 0.856 0.812 0.927 0.253
16. L3032LG494_3 ClusPro ligand_L0R_B_1.mol 0.856 0.812 0.927 0.253
17. L3032LG055_1 LCDD-team ligand_L0R_B_1.mol 0.832 1.228 0.922 0.252
18. L3032LG408_4 SNU-CHEM-lig ligand_L0R_B_1.mol 0.825 1.051 0.895 0.282
19. L3032LG207_3 MULTICOM_ligand ligand_L0R_B_1.mol 0.811 0.918 0.871 0.392
20. L3032LG207_1 MULTICOM_ligand ligand_L0R_B_1.mol 0.803 0.858 0.871 0.392
21. L3032LG207_2 MULTICOM_ligand ligand_L0R_B_1.mol 0.801 1.042 0.871 0.392
22. L3032LG204_1 Zou ligand_L0R_B_1.mol 0.798 1.738 0.898 0.324
23. L3032LG204_5 Zou ligand_L0R_B_1.mol 0.770 1.446 0.897 0.316
24. L3032LG008_1 HADDOCK ligand_L0R_B_1.mol 0.676 1.797 0.886 0.390
25. L3032LG008_4 HADDOCK ligand_L0R_B_1.mol 0.644 2.323 0.894 0.417
26. L3032LG204_4 Zou ligand_L0R_B_1.mol 0.621 3.343 0.909 0.351
27. L3032LG420_2 Zou_aff2 ligand_L0R_B_1.mol 0.621 3.343 0.909 0.351
28. L3032LG055_5 LCDD-team ligand_L0R_B_1.mol 0.604 3.297 0.922 0.252
29. L3032LG016_3 haiping ligand_L0R_B_1.mol 0.552 2.747 0.885 0.336
30. L3032LG294_2 KiharaLab ligand_L0R_B_1.mol 0.543 3.083 0.894 0.336
31. L3032LG309_2 Koes ligand_L0R_B_1.mol 0.541 1.802 0.621 1.731
32. L3032LG309_1 Koes ligand_L0R_B_1.mol 0.538 1.826 0.621 1.731
33. L3032LG309_4 Koes ligand_L0R_B_1.mol 0.531 1.730 0.621 1.698
34. L3032LG207_4 MULTICOM_ligand ligand_L0R_B_1.mol 0.504 3.650 0.773 0.501
35. L3032LG167_1 OpenComplex ligand_L0R_B_1.mol 0.488 3.108 0.703 0.813
36. L3032LG016_5 haiping ligand_L0R_B_1.mol 0.460 3.599 0.885 0.336
37. L3032LG201_5 Drugit ligand_L0R_B_1.mol 0.453 3.896 0.693 0.714
38. L3032LG207_5 MULTICOM_ligand ligand_L0R_B_1.mol 0.452 4.174 0.800 0.448
39. L3032LG201_1 Drugit ligand_L0R_B_1.mol 0.445 3.892 0.685 0.597
40. L3032LG055_2 LCDD-team ligand_L0R_B_1.mol 0.427 4.768 0.922 0.252
41. L3032LG408_5 SNU-CHEM-lig ligand_L0R_B_1.mol 0.401 5.370 0.779 0.997
42. L3032LG432_3 DIMAIO ligand_L0R_B_1.mol 0.389 5.510 0.819 0.563
43. L3032LG432_2 DIMAIO ligand_L0R_B_1.mol 0.349 6.380 0.724 0.966
44. L3032LG262_4 CoDock ligand_L0R_B_1.mol 0.328 5.179 0.916 0.336
45. L3032LG008_2 HADDOCK ligand_L0R_B_1.mol 0.318 6.505 0.878 0.402
46. L3032LG408_1 SNU-CHEM-lig ligand_L0R_B_1.mol 0.318 6.720 0.926 0.338
47. L3032LG008_5 HADDOCK ligand_L0R_B_1.mol 0.314 6.552 0.858 0.453
48. L3032LG055_4 LCDD-team ligand_L0R_B_1.mol 0.311 6.393 0.922 0.252
49. L3032LG204_3 Zou ligand_L0R_B_1.mol 0.309 6.904 0.893 0.366
50. L3032LG191_3 Schneidman ligand_L0R_B_1.mol 0.307 4.946 0.600 1.984
51. L3032LG055_3 LCDD-team ligand_L0R_B_1.mol 0.297 7.224 0.922 0.252
52. L3032LG201_4 Drugit ligand_L0R_B_1.mol 0.294 7.254 0.718 0.671
53. L3032LG164_5 McGuffin ligand_L0R_B_1.mol 0.294 6.243 0.608 1.681
54. L3032LG164_4 McGuffin ligand_L0R_B_1.mol 0.291 6.201 0.608 1.681
55. L3032LG164_3 McGuffin ligand_L0R_B_1.mol 0.291 6.251 0.608 1.681
56. L3032LG420_4 Zou_aff2 ligand_L0R_B_1.mol 0.287 7.445 0.786 0.748
57. L3032LG164_1 McGuffin ligand_L0R_B_1.mol 0.286 6.247 0.608 1.681
58. L3032LG450_1 OpenComplex_Server ligand_L0R_B_1.mol 0.277 7.334 0.880 0.393
59. L3032LG191_1 Schneidman ligand_L0R_B_1.mol 0.266 4.731 0.603 1.811
60. L3032LG432_1 DIMAIO ligand_L0R_B_1.mol 0.264 6.794 0.890 0.416
61. L3032LG082_1 VnsDock ligand_L0R_B_1.mol 0.261 7.708 0.867 0.471
62. L3032LG262_2 CoDock ligand_L0R_B_1.mol 0.243 7.028 0.716 0.906
63. L3032LG201_3 Drugit ligand_L0R_B_1.mol 0.239 7.586 0.717 0.642
64. L3032LG294_1 KiharaLab ligand_L0R_B_1.mol 0.238 7.254 0.894 0.336
65. L3032LG227_5 KUMC ligand_L0R_B_1.mol 0.238 7.801 0.850 0.468
66. L3032LG227_4 KUMC ligand_L0R_B_1.mol 0.237 7.793 0.848 0.471
67. L3032LG227_1 KUMC ligand_L0R_B_1.mol 0.235 7.839 0.850 0.468
68. L3032LG227_2 KUMC ligand_L0R_B_1.mol 0.233 7.882 0.850 0.468
69. L3032LG227_3 KUMC ligand_L0R_B_1.mol 0.233 7.840 0.850 0.468
70. L3032LG167_2 OpenComplex ligand_L0R_B_1.mol 0.231 6.280 0.603 1.236
71. L3032LG262_3 CoDock ligand_L0R_B_1.mol 0.231 7.297 0.716 0.906
72. L3032LG016_4 haiping ligand_L0R_B_1.mol 0.224 7.867 0.885 0.336
73. L3032LG450_3 OpenComplex_Server ligand_L0R_B_1.mol 0.222 8.511 0.880 0.393
74. L3032LG420_3 Zou_aff2 ligand_L0R_B_1.mol 0.205 8.198 0.852 0.487
75. L3032LG450_2 OpenComplex_Server ligand_L0R_B_1.mol 0.192 8.754 0.880 0.393
76. L3032LG091_4 Huang-HUST ligand_L0R_B_1.mol 0.181 8.393 0.709 0.797
77. L3032LG420_5 Zou_aff2 ligand_L0R_B_1.mol 0.179 7.609 0.892 0.548
78. L3032LG091_3 Huang-HUST ligand_L0R_B_1.mol 0.176 8.093 0.706 1.208
79. L3032LG450_4 OpenComplex_Server ligand_L0R_B_1.mol 0.169 9.373 0.880 0.393
80. L3032LG386_5 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.169 8.326 0.885 0.390
81. L3032LG298_5 ShanghaiTech-human ligand_L0R_B_1.mol 0.169 8.326 0.885 0.390
82. L3032LG091_1 Huang-HUST ligand_L0R_B_1.mol 0.160 8.560 0.722 1.000
83. L3032LG020_3 comppharmunibas ligand_L0R_B_1.mol 0.154 9.107 0.904 0.293
84. L3032LG091_5 Huang-HUST ligand_L0R_B_1.mol 0.153 8.827 0.722 1.000
85. L3032LG386_1 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.153 8.332 0.873 0.441
86. L3032LG298_1 ShanghaiTech-human ligand_L0R_B_1.mol 0.153 8.332 0.873 0.441
87. L3032LG298_4 ShanghaiTech-human ligand_L0R_B_1.mol 0.152 8.705 0.885 0.390
88. L3032LG386_4 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.152 8.705 0.885 0.390
89. L3032LG008_3 HADDOCK ligand_L0R_B_1.mol 0.149 8.335 0.853 0.487
90. L3032LG309_3 Koes ligand_L0R_B_1.mol 0.148 10.203 0.618 1.710
91. L3032LG298_2 ShanghaiTech-human ligand_L0R_B_1.mol 0.147 8.535 0.885 0.390
92. L3032LG386_2 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.147 8.535 0.885 0.390
93. L3032LG464_5 PocketTracer ligand_L0R_B_1.mol 0.146 11.450 0.607 1.750
94. L3032LG464_4 PocketTracer ligand_L0R_B_1.mol 0.130 12.328 0.607 1.750
95. L3032LG201_2 Drugit ligand_L0R_B_1.mol 0.130 7.569 0.771 0.943
96. L3032LG464_3 PocketTracer ligand_L0R_B_1.mol 0.122 11.840 0.607 1.750
97. L3032LG020_1 comppharmunibas ligand_L0R_B_1.mol 0.114 10.380 0.904 0.293
98. L3032LG298_3 ShanghaiTech-human ligand_L0R_B_1.mol 0.104 10.590 0.885 0.390
99. L3032LG386_3 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.104 10.590 0.885 0.390
100. L3032LG020_5 comppharmunibas ligand_L0R_B_1.mol 0.104 10.958 0.904 0.293
101. L3032LG091_2 Huang-HUST ligand_L0R_B_1.mol 0.090 11.989 0.934 0.227
102. L3032LG016_1 haiping ligand_L0R_B_1.mol 0.083 10.226 0.885 0.336
103. L3032LG464_1 PocketTracer ligand_L0R_B_1.mol 0.082 10.616 0.607 1.750
104. L3032LG450_5 OpenComplex_Server ligand_L0R_B_1.mol 0.077 10.297 0.880 0.393
105. L3032LG167_3 OpenComplex ligand_L0R_B_1.mol 0.072 9.396 0.522 1.658
106. L3032LG016_2 haiping ligand_L0R_B_1.mol 0.044 11.300 0.885 0.336
107. L3032LG167_4 OpenComplex ligand_L0R_B_1.mol 0.023 13.530 0.616 1.280
108. L3032LG464_2 PocketTracer ligand_L0R_B_1.mol 0.011 17.189 0.607 1.750
109. L3032LG167_5 OpenComplex ligand_L0R_B_1.mol 0.000 21.762 0.639 0.950
110. L3032LG164_2 McGuffin ligand_L0R_B_1.mol 0.000 33.376 0.612 1.689
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use